Mitsubishi UFJ Asset Management Co. Ltd. Has $553,000 Position in The Chemours Company $CC

Mitsubishi UFJ Asset Management Co. Ltd. raised its position in The Chemours Company (NYSE:CC) by 129.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 48,314 shares of the specialty chemicals company’s stock after purchasing an additional 27,248 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Chemours were worth $553,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in CC. SouthState Corp acquired a new position in shares of Chemours in the first quarter valued at approximately $34,000. GAMMA Investing LLC grew its holdings in Chemours by 130.7% during the 2nd quarter. GAMMA Investing LLC now owns 3,175 shares of the specialty chemicals company’s stock worth $36,000 after acquiring an additional 1,799 shares during the last quarter. FNY Investment Advisers LLC grew its holdings in Chemours by 100.0% during the 2nd quarter. FNY Investment Advisers LLC now owns 4,000 shares of the specialty chemicals company’s stock worth $45,000 after acquiring an additional 2,000 shares during the last quarter. CWM LLC increased its position in Chemours by 34.7% in the 2nd quarter. CWM LLC now owns 4,290 shares of the specialty chemicals company’s stock valued at $49,000 after acquiring an additional 1,104 shares during the period. Finally, Parallel Advisors LLC raised its stake in shares of Chemours by 132.6% during the second quarter. Parallel Advisors LLC now owns 5,634 shares of the specialty chemicals company’s stock valued at $65,000 after acquiring an additional 3,212 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages recently weighed in on CC. Royal Bank Of Canada reduced their price objective on shares of Chemours from $19.00 to $17.00 and set an “outperform” rating on the stock in a research note on Monday, November 10th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Chemours in a report on Wednesday, October 8th. Mizuho decreased their price target on Chemours from $19.00 to $18.00 and set an “outperform” rating for the company in a research note on Thursday, October 16th. Truist Financial lowered their price objective on Chemours from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Monday, November 10th. Finally, Zacks Research cut Chemours from a “hold” rating to a “strong sell” rating in a report on Friday, October 17th. Five equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Chemours currently has an average rating of “Hold” and a consensus price target of $17.50.

Chemours Stock Down 3.3%

Shares of NYSE:CC opened at $11.87 on Friday. The Chemours Company has a 1 year low of $9.13 and a 1 year high of $22.38. The company has a debt-to-equity ratio of 13.66, a current ratio of 1.71 and a quick ratio of 0.88. The business’s 50-day moving average is $14.60 and its 200-day moving average is $13.23. The company has a market capitalization of $1.78 billion, a price-to-earnings ratio of -5.35 and a beta of 1.64.

Chemours (NYSE:CC) last released its earnings results on Thursday, November 6th. The specialty chemicals company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.24 by ($0.04). The business had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.50 billion. Chemours had a positive return on equity of 35.27% and a negative net margin of 5.70%.The company’s revenue for the quarter was down .9% on a year-over-year basis. During the same period in the prior year, the business earned $0.40 EPS. Chemours has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. Equities research analysts predict that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Friday, November 14th will be paid a $0.0875 dividend. The ex-dividend date is Friday, November 14th. This represents a $0.35 annualized dividend and a dividend yield of 2.9%. Chemours’s payout ratio is currently -15.77%.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.